Cargando…
Testosterone Replacement Therapy and Cardiovascular Risk: A Review
Recent reports in the scientific and lay press have suggested that testosterone (T) replacement therapy (TRT) is likely to increase cardiovascular (CV) risk. In a final report released in 2015, the Food and Drug Administration (FDA) cautioned that prescribing T products is approved only for men who...
Autores principales: | Corona G, Giovanni, Rastrelli, Giulia, Maseroli, Elisa, Sforza, Alessandra, Maggi, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Sexual Medicine and Andrology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709429/ https://www.ncbi.nlm.nih.gov/pubmed/26770933 http://dx.doi.org/10.5534/wjmh.2015.33.3.130 |
Ejemplares similares
-
Corrigendum: Testosterone Replacement Therapy and Cardiovascular Risk: A Review
por: Corona, Giovanni, et al.
Publicado: (2016) -
Testosterone Deficiency and Risk of Cognitive Disorders in Aging Males
por: Corona, Giovanni, et al.
Publicado: (2021) -
Testosterone Replacement Therapy: Long-Term Safety and Efficacy
por: Corona, Giovanni, et al.
Publicado: (2017) -
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
por: Corona, Giovanni, et al.
Publicado: (2021) -
Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction
por: Rastrelli, Giulia, et al.
Publicado: (2019)